Connection

Co-Authors

This is a "connection" page, showing publications co-authored by SHARON HERMES GIORDANO and THOMAS A BUCHHOLZ.
Connection Strength

2.968
  1. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1022-7.
    View in: PubMed
    Score: 0.312
  2. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer. 2016 Mar 15; 122(6):917-28.
    View in: PubMed
    Score: 0.135
  3. Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. J Clin Oncol. 2014 Jul 01; 32(19):2010-7.
    View in: PubMed
    Score: 0.121
  4. Determinants of practice patterns and quality gaps in lung cancer staging and diagnosis. Chest. 2014 May; 145(5):1097-1113.
    View in: PubMed
    Score: 0.120
  5. Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest. 2014 Feb; 145(2):331-345.
    View in: PubMed
    Score: 0.118
  6. Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol. 2013 Nov 20; 31(33):4222-8.
    View in: PubMed
    Score: 0.116
  7. Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev. 2012 May; 21(5):800-9.
    View in: PubMed
    Score: 0.104
  8. Anthracycline regimen adherence in older patients with early breast cancer. Oncologist. 2012; 17(3):303-11.
    View in: PubMed
    Score: 0.103
  9. Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol. 2011 Dec 10; 29(35):4647-53.
    View in: PubMed
    Score: 0.101
  10. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst. 2011 May 18; 103(10):798-809.
    View in: PubMed
    Score: 0.098
  11. Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol. 2011 Nov; 22(11):2394-2402.
    View in: PubMed
    Score: 0.097
  12. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer. 2010 Feb 01; 116(3):734-41.
    View in: PubMed
    Score: 0.090
  13. A method to predict breast cancer stage using Medicare claims. Epidemiol Perspect Innov. 2010 Jan 15; 7:1.
    View in: PubMed
    Score: 0.089
  14. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg. 2009 Oct; 209(4):425-433.e2.
    View in: PubMed
    Score: 0.087
  15. Completion of adjuvant radiation therapy among women with breast cancer. Cancer. 2008 Jul 01; 113(1):22-9.
    View in: PubMed
    Score: 0.080
  16. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer. 2008 Mar 15; 112(6):1371-9.
    View in: PubMed
    Score: 0.079
  17. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006 Nov 01; 24(31):4971-5.
    View in: PubMed
    Score: 0.071
  18. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Cancer. 2006 Jun 15; 106(12):2556-62.
    View in: PubMed
    Score: 0.070
  19. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005 Oct 20; 23(30):7475-82.
    View in: PubMed
    Score: 0.066
  20. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005 Mar 16; 97(6):419-24.
    View in: PubMed
    Score: 0.064
  21. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2019 02 10; 37(5):423-438.
    View in: PubMed
    Score: 0.041
  22. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst. 2017 01; 109(1).
    View in: PubMed
    Score: 0.036
  23. Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes. Ann Surg Oncol. 2016 08; 23(8):2385-90.
    View in: PubMed
    Score: 0.034
  24. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. J Clin Oncol. 2016 05 10; 34(14):1689-701.
    View in: PubMed
    Score: 0.034
  25. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform. Int J Radiat Oncol Biol Phys. 2016 06 01; 95(2):605-16.
    View in: PubMed
    Score: 0.034
  26. Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis. Ann Surg. 2016 Feb; 263(2):219-27.
    View in: PubMed
    Score: 0.034
  27. Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol. 2015 May; 115(2):257-63.
    View in: PubMed
    Score: 0.032
  28. Utilization and Outcomes of Breast Brachytherapy in Younger Women. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):91-101.
    View in: PubMed
    Score: 0.032
  29. Physician variation in management of low-risk prostate cancer: a population-based cohort study. JAMA Intern Med. 2014 Sep; 174(9):1450-9.
    View in: PubMed
    Score: 0.031
  30. Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study. J Clin Oncol. 2014 Jul 20; 32(21):2206-16.
    View in: PubMed
    Score: 0.030
  31. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol. 2014 Jul 20; 32(21):2255-69.
    View in: PubMed
    Score: 0.030
  32. Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States. J Oncol Pract. 2014 Jul; 10(4):e269-76.
    View in: PubMed
    Score: 0.030
  33. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014 Mar 20; 32(9):919-26.
    View in: PubMed
    Score: 0.030
  34. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):274-84.
    View in: PubMed
    Score: 0.029
  35. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):686-93.
    View in: PubMed
    Score: 0.028
  36. Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Ann Surg Oncol. 2013 May; 20(5):1514-21.
    View in: PubMed
    Score: 0.027
  37. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol. 2013 Jan 01; 31(1):80-7.
    View in: PubMed
    Score: 0.027
  38. A population-based study of the quality of care in the diagnosis of large (=5 cm) soft tissue sarcomas. Am J Clin Oncol. 2012 Oct; 35(5):455-61.
    View in: PubMed
    Score: 0.027
  39. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery. Cancer. 2012 Oct 01; 118(19):4642-51.
    View in: PubMed
    Score: 0.027
  40. Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol. 2012 Aug 10; 30(23):2837-43.
    View in: PubMed
    Score: 0.026
  41. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012 May 02; 307(17):1827-37.
    View in: PubMed
    Score: 0.026
  42. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer. 2011 Oct 15; 117(20):4595-605.
    View in: PubMed
    Score: 0.025
  43. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol. 2011 Jan 10; 29(2):157-65.
    View in: PubMed
    Score: 0.024
  44. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. 2010 Aug 10; 28(23):3784-96.
    View in: PubMed
    Score: 0.023
  45. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009 Apr 20; 27(12):2007-14.
    View in: PubMed
    Score: 0.021
  46. Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol. 2009 Jan 10; 27(2):220-6.
    View in: PubMed
    Score: 0.021
  47. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 2008 Nov 01; 26(31):5119-25.
    View in: PubMed
    Score: 0.020
  48. Trends for inflammatory breast cancer: is survival improving? Oncologist. 2007 Aug; 12(8):904-12.
    View in: PubMed
    Score: 0.019
  49. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol. 2006 Apr; 17(4):605-13.
    View in: PubMed
    Score: 0.017
  50. Squamous cell carcinoma of the breast. J Clin Oncol. 2005 Nov 01; 23(31):7827-35.
    View in: PubMed
    Score: 0.017
  51. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol. 2005 Jun 01; 23(16):3676-85.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.